$QBTS stock fell 6% this week, according to our price data from Polygon.
It has been the 34th most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $QBTS (you can track the company live on Quiver's $QBTS stock page):
$QBTS Insider Trading Activity
$QBTS insiders have traded $QBTS stock on the open market 30 times in the past 6 months. Of those trades, 1 have been purchases and 29 have been sales.
Here’s a breakdown of recent trading of $QBTS stock by insiders over the last 6 months:
- ALAN E BARATZ (President & CEO) has made 0 purchases and 4 sales selling 1,799,471 shares for an estimated $52,457,369.
- JOHN M. MARKOVICH (Chief Financial Officer) has made 0 purchases and 11 sales selling 867,616 shares for an estimated $20,055,053.
- DIANE NGUYEN (EVP, Chief Legal Officer & GC) has made 0 purchases and 7 sales selling 115,633 shares for an estimated $2,773,902.
- STEVEN M WEST has made 1 purchase buying 82 shares for an estimated $1,794 and 2 sales selling 144,000 shares for an estimated $2,603,540.
- ROHIT GHAI has made 0 purchases and 2 sales selling 20,000 shares for an estimated $422,161.
- JOHN D DILULLO has made 0 purchases and 2 sales selling 16,000 shares for an estimated $362,321.
- KIRSTJEN NIELSEN sold 7,000 shares for an estimated $158,340
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$QBTS Hedge Fund Activity
We have seen 314 institutional investors add shares of $QBTS stock to their portfolio, and 150 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 11,218,255 shares (+41.2%) to their portfolio in Q3 2025, for an estimated $277,203,081
- UBS GROUP AG added 10,205,427 shares (+541.6%) to their portfolio in Q3 2025, for an estimated $252,176,101
- BANK OF AMERICA CORP /DE/ removed 9,325,387 shares (-63.3%) from their portfolio in Q3 2025, for an estimated $230,430,312
- PRICE T ROWE ASSOCIATES INC /MD/ added 3,745,315 shares (+448.3%) to their portfolio in Q3 2025, for an estimated $92,546,733
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 3,099,209 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $76,581,454
- BLACKROCK, INC. added 2,975,256 shares (+12.8%) to their portfolio in Q3 2025, for an estimated $73,518,575
- MAREX GROUP PLC removed 2,843,135 shares (-52.0%) from their portfolio in Q3 2025, for an estimated $70,253,865
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$QBTS Analyst Ratings
Wall Street analysts have issued reports on $QBTS in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wedbush issued a "Outperform" rating on 12/17/2025
- Mizuho issued a "Outperform" rating on 12/11/2025
- Benchmark issued a "Buy" rating on 11/10/2025
- Rosenblatt issued a "Buy" rating on 11/07/2025
- Canaccord Genuity issued a "Buy" rating on 11/07/2025
- Cantor Fitzgerald issued a "Overweight" rating on 11/07/2025
- Piper Sandler issued a "Overweight" rating on 08/08/2025
To track analyst ratings and price targets for $QBTS, check out Quiver Quantitative's $QBTS forecast page.
$QBTS Price Targets
Multiple analysts have issued price targets for $QBTS recently. We have seen 12 analysts offer price targets for $QBTS in the last 6 months, with a median target of $37.5.
Here are some recent targets:
- Antoine Legault from Wedbush set a target price of $35.0 on 12/17/2025
- Kevin Garrigan from Jefferies set a target price of $45.0 on 12/16/2025
- Vijay Rakesh from Mizuho set a target price of $46.0 on 12/11/2025
- Mark Lipacis from Evercore ISI Group set a target price of $44.0 on 12/03/2025
- David Williams from Benchmark set a target price of $35.0 on 11/10/2025
- John McPeake from Rosenblatt set a target price of $40.0 on 11/07/2025
- Troy Jensen from Cantor Fitzgerald set a target price of $40.0 on 11/07/2025
You can track data on $QBTS on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
